What is the price target for AH stock?
8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.
TSX:AH • CA01444Q1046
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Aleafia Health Inc (AH.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-02-16 | Raymond James Capital | Initiate | Market Perform |
| 2022-02-14 | Raymond James Financial | Downgrade | Market Perform |
| 2021-11-12 | RaymondJamesFinancial | Downgrade | Market Perform |
| 2021-08-11 | Raymond James Financial | Downgrade | Outperform |
| 2021-06-17 | Raymond James Financial | Initiate | Outperform |
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44.54M 172.42% | 36.08M -18.99% | 42.847M 18.76% | 76.426M 78.37% | 87.653M 14.69% | |
| EBITDA YoY % growth | -37.34M -106.53% | -54.91M -47.05% | -11.693M 78.71% | 15.999M 236.83% | 8.446M -47.21% | |
| EBIT YoY % growth | -47.5M -98.00% | -65.19M -37.24% | -18.258M 71.99% | -4.326M 76.31% | 927K 121.43% | |
| Operating Margin | -106.65% | -180.68% | -42.61% | -5.66% | 1.06% | |
| EPS YoY % growth | -0.27 -482.52% | N/A 75.20% | N/A 23.08% | -0.03 40.00% | -0.03 |
All data in CAD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.04 -300.00% |
| Revenue Q2Q % growth | 19.776M 110.52% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -309K 95.96% |
All data in CAD
8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.
The consensus EPS estimate for the next earnings of Aleafia Health Inc (AH.CA) is -0.04 CAD and the consensus revenue estimate is 19.78M CAD.
The number of analysts covering Aleafia Health Inc (AH.CA) is 8.